Secondary parkinsonism is a syndrome that manifests itself with symptoms similar to Parkinson's disease, but has a high degree of secondary nature, arising as a result of various diseases, toxic effects, injuries, infections or certain pharmacological drugs. Unlike primary Parkinson's disease, secondary parkinsonism can be temporary or chronic, depending on the etiology. Classification of this condition is tied to a thorough analysis of the causes, which can help choose a more effective treatment strategy. The most characteristic manifestations of secondary parkinsonism are acrania, bradykinesia, tremor, rigidity and postural disorders.
History of the disease and interesting historical facts
Historically, the symptoms of Parkinsonism were known long before the disease itself was described in detail. There are references in medical texts dating back to ancient times. Comparisons of these manifestations with more modern data can be made by analyzing descriptions such as “fluttering” and “uncontrolled movements”. However, the term “Parkinsonism” was introduced in the 19th century after the research of James Parkinson, who described the disease that today bears his name. Interestingly, many patients with Parkinsonism attacks in ancient times were treated as demonically possessed or unfortunate people, which indicates a low level of medical knowledge. With the discovery of neurobiology and neuropharmacology in the 20th century, the study of secondary Parkinsonism received new impetus, which made it possible to distinguish between primary and secondary Parkinsonism with greater accuracy.
Epidemiology
Secondary parkinsonism is much less common than primary parkinsonism, although its persistent nature makes it an important clinical problem. According to studies, about 10-20% patients who experience parkinsonism symptoms have a secondary etiology. The incidence of secondary parkinsonism varies with geographic area, level of health care, and prevalence of risk factors. Studies show that secondary parkinsonism is more common among older people due to comorbidities and exposure to unfavorable environmental factors. It is important to note that such statistics may vary across different regions and populations.
Genetic predisposition to this disease
In secondary parkinsonism, genetic mutations play a lesser role compared to primary parkinsonism. However, some drugs and toxic substances may affect genetic mechanisms, increasing the risk of parkinsonism. In contrast to hereditary parkinsonism, where mutations in genes such as SNCA, PARK2, PARK7, and GBA are studied, secondary parkinsonism is most often not associated with heredity. Some genetic predispositions may be observed in patients with occupational diseases or with a history of toxic effects on the body, which emphasizes the need to evaluate genetic factors in certain clinical cases.
Risk factors for the development of this disease
There are several known risk factors that may contribute to the development of secondary parkinsonism:
- Neurological diseases: such as stroke, brain tumors and head injuries.
- Chemicals: Long-term exposure to poisons and toxins such as carbon monoxide and certain heavy metals.
- Medications: Some medications, particularly antipsychotics and antiemetics, can cause Parkinsonian symptoms as a side effect.
- Infections: Such as encephalitis, which can damage neurons.
- Metabolic disorders such as hypothyroidism or vitamin B12 deficiency may also contribute to this syndrome.
Diagnosis of this disease
Diagnosis of secondary parkinsonism requires a comprehensive approach, including both clinical and instrumental studies. The main symptoms of the disease include:
- Bradykinesia is slowness of movement.
- Tremor is shaking, especially when at rest.
- Rigidity is the stiffness of muscles, difficulty in performing movements.
- Impaired balance and coordination.
Laboratory tests may include complete blood count, biochemistry, and vitamin levels. Radiological examinations most often include MRI or CT of the head to rule out structural changes and tumors. Other diagnostics may include an electroencephalogram (EEG) to assess brain activity. An important aspect is differential diagnosis, which allows us to distinguish secondary parkinsonism from primary parkinsonism, as well as to rule out conditions such as drug-induced Parkinson's syndrome.
Treatment
Treatment of secondary parkinsonism should be individualized and based on the specific etiology of the condition. In general, it includes:
- Pharmacological treatment: use of drugs that improve dopamine transmission - levodopa, dopamine agonists.
- Physiotherapy: Provides improved motor function and symptom relief.
- Surgical treatment: In cases of purulent infections, surgery may be indicated to remove the affected tissue.
- Supportive therapy: includes exercise and work with occupational therapists.
List of medications used to treat this disease
The main medications used to treat secondary parkinsonism include:
- Levodopa
- Bromocriptine
- Ropinirole
- Pragrepexol
- Anticholinergic drugs
Disease monitoring
Monitoring the condition of patients with secondary parkinsonism requires regular monitoring of symptoms and assessment of their progression. Key monitoring steps include:
- Regular neurological examinations to assess the dynamics of symptoms.
- Measuring functional indicators through specialized scales, such as the UPDRS.
- Screening for side effects from prescribed medications.
The prognosis for patients with secondary Parkinsonism depends on the etiology of the disease: if the causes are successfully eliminated, the symptoms may significantly decrease, but in chronic cases, complications such as falls, depression or dementia may develop.
Age-related features of the disease
Secondary Parkinsonism has its own characteristics of manifestation in different age groups. In elderly people, the disease is most often associated with vascular lesions and metabolic factors. In young people, the body's resistance to the effects of toxins and injuries can lead to faster and more acute manifestations of the disease. In childhood, secondary Parkinsonism is rarer and is often associated with infectious or genetic disorders.
Questions and Answers
- What is secondary parkinsonism? Secondary parkinsonism is a syndrome that occurs as a consequence of other diseases or influences that contribute to the development of parkinsonism.
- What are the main causes of secondary parkinsonism? The main causes include neurological diseases, toxic effects, infections and certain medications.
- How is secondary parkinsonism diagnosed? Diagnosis includes clinical examination, laboratory and radiological studies, which helps to exclude primary Parkinsonism and other conditions.
- Is it possible to treat secondary Parkinsonism? Yes, treatment is possible and includes pharmacological and physical therapy, and, in some cases, surgical intervention.
- What is the prognosis for patients with secondary parkinsonism? The prognosis depends on the cause of the disease: if the causes are successfully eliminated, the symptoms may be significantly reduced; otherwise, the condition may progress.
